Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group.

Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28. Erratum in: Osteoporos Int. 2009 Mar;20(3):499-502.

PMID:
18751937
2.

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P.

BMJ. 2008 Jun 28;336(7659):1475-82. doi: 10.1136/bmj.39609.449676.25. Epub 2008 Jun 23.

3.

Electronic health records, medical research, and the Tower of Babel.

Kush RD, Helton E, Rockhold FW, Hardison CD.

N Engl J Med. 2008 Apr 17;358(16):1738-40. doi: 10.1056/NEJMsb0800209. No abstract available.

PMID:
18420507
4.

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML; WHI Investigators.

JAMA. 2008 Mar 5;299(9):1036-45. doi: 10.1001/jama.299.9.1036.

PMID:
18319414
5.

Identifying undiagnosed diabetes: cross-sectional survey of 3.6 million patients' electronic records.

Holt TA, Stables D, Hippisley-Cox J, O'Hanlon S, Majeed A.

Br J Gen Pract. 2008 Mar;58(548):192-6. doi: 10.3399/bjgp08X277302.

6.

FRAX and the assessment of fracture probability in men and women from the UK.

Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E.

Osteoporos Int. 2008 Apr;19(4):385-97. doi: 10.1007/s00198-007-0543-5. Epub 2008 Feb 22.

7.

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

Dawson-Hughes B, Tosteson AN, Melton LJ 3rd, Baim S, Favus MJ, Khosla S, Lindsay RL; National Osteoporosis Foundation Guide Committee.

Osteoporos Int. 2008 Apr;19(4):449-58. doi: 10.1007/s00198-008-0559-5. Epub 2008 Feb 22.

PMID:
18292975
8.

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z. Epub 2008 Feb 12. Review. Erratum in: Osteoporos Int. 2008 Jul;19(7): 1103-4..

9.

Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis.

Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J.

JAMA. 2007 Dec 12;298(22):2654-64. Review.

PMID:
18073361
10.

Comment on Kanis et al.: the use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

Moayyeri A.

Osteoporos Int. 2008 Apr;19(4):591-2; author reply 593-4. Epub 2007 Dec 8. No abstract available.

PMID:
18066609
11.

Factors associated with 5-year risk of hip fracture in postmenopausal women.

Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J.

JAMA. 2007 Nov 28;298(20):2389-98.

PMID:
18042916
12.

Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P.

Heart. 2008 Jan;94(1):34-9. Epub 2007 Oct 4.

PMID:
17916661
13.

Imputation is beneficial for handling missing data in predictive models.

Steyerberg EW, van Veen M.

J Clin Epidemiol. 2007 Sep;60(9):979. Epub 2007 Jun 28. No abstract available.

PMID:
17689816
14.

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P.

BMJ. 2007 Jul 21;335(7611):136. Epub 2007 Jul 5.

15.

Risk of hip fracture in patients with a history of schizophrenia.

Howard L, Kirkwood G, Leese M.

Br J Psychiatry. 2007 Feb;190:129-34.

16.

Long-term proton pump inhibitor therapy and risk of hip fracture.

Yang YX, Lewis JD, Epstein S, Metz DC.

JAMA. 2006 Dec 27;296(24):2947-53.

PMID:
17190895
17.

Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study.

McCloskey EV, Beneton M, Charlesworth D, Kayan K, deTakats D, Dey A, Orgee J, Ashford R, Forster M, Cliffe J, Kersh L, Brazier J, Nichol J, Aropuu S, Jalava T, Kanis JA.

J Bone Miner Res. 2007 Jan;22(1):135-41.

18.

Using the outcome for imputation of missing predictor values was preferred.

Moons KG, Donders RA, Stijnen T, Harrell FE Jr.

J Clin Epidemiol. 2006 Oct;59(10):1092-101. Epub 2006 Jun 19.

PMID:
16980150
19.

Body mass index as a predictor of fracture risk: a meta-analysis.

De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ 3rd, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A.

Osteoporos Int. 2005 Nov;16(11):1330-8. Epub 2005 Jun 1. Review.

PMID:
15928804
20.

Hip fracture in women without osteoporosis.

Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES; Study of Osteoporotic Fractures Research Group.

J Clin Endocrinol Metab. 2005 May;90(5):2787-93. Epub 2005 Feb 22.

PMID:
15728213

Supplemental Content

Support Center